1. Home
  2. BUSE vs LMAT Comparison

BUSE vs LMAT Comparison

Compare BUSE & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Busey Corporation

BUSE

First Busey Corporation

HOLD

Current Price

$26.29

Market Cap

2.1B

Sector

Finance

ML Signal

HOLD

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

HOLD

Current Price

$111.94

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BUSE
LMAT
Founded
1868
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.6B
IPO Year
1996
2006

Fundamental Metrics

Financial Performance
Metric
BUSE
LMAT
Price
$26.29
$111.94
Analyst Decision
Buy
Buy
Analyst Count
7
5
Target Price
$27.00
$105.80
AVG Volume (30 Days)
560.2K
194.6K
Earning Date
04-28-2026
05-05-2026
Dividend Yield
3.91%
0.87%
EPS Growth
N/A
30.57
EPS
1.47
2.52
Revenue
$719,584,000.00
$249,602,000.00
Revenue This Year
$23.84
$14.21
Revenue Next Year
$3.82
$8.88
P/E Ratio
$18.09
$45.61
Revenue Growth
55.66
13.53
52 Week Low
$19.55
$78.01
52 Week High
$27.65
$118.01

Technical Indicators

Market Signals
Indicator
BUSE
LMAT
Relative Strength Index (RSI) 57.16 57.80
Support Level $23.78 $81.60
Resistance Level $27.09 $113.40
Average True Range (ATR) 0.46 3.18
MACD 0.12 -0.01
Stochastic Oscillator 68.60 62.87

Price Performance

Historical Comparison
BUSE
LMAT

About BUSE First Busey Corporation

First Busey Corporation is a financial holding company whose subsidiaries provide retail and commercial banking services, remittance processing, and offer financial products and services with banking centers in Illinois, Missouri, Florida, and Indiana. The company's operations are managed through three operating segments consisting of Banking, FirsTech, and Wealth Management. The banking segment generates a vast majority of its revenue.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.

Share on Social Networks: